131 related articles for article (PubMed ID: 27447860)
1. Seven protective miRNA signatures for prognosis of cervical cancer.
Liu B; Ding JF; Luo J; Lu L; Yang F; Tan XD
Oncotarget; 2016 Aug; 7(35):56690-56698. PubMed ID: 27447860
[TBL] [Abstract][Full Text] [Related]
2. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
Liang B; Li Y; Wang T
Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection.
Azizmohammadi S; Safari A; Azizmohammadi S; Kaghazian M; Sadrkhanlo M; Yahaghi E; Farshgar R; Seifoleslami M
QJM; 2017 Jan; 110(1):11-15. PubMed ID: 27345415
[TBL] [Abstract][Full Text] [Related]
4. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.
Yang Y; Song KL; Chang H; Chen L
Diagn Pathol; 2014 Dec; 9():220. PubMed ID: 25551621
[TBL] [Abstract][Full Text] [Related]
6. A microRNA expression signature for clinical response in locally advanced cervical cancer.
Pedroza-Torres A; Fernández-Retana J; Peralta-Zaragoza O; Jacobo-Herrera N; Cantú de Leon D; Cerna-Cortés JF; Lopez-Camarillo C; Pérez-Plasencia C
Gynecol Oncol; 2016 Sep; 142(3):557-65. PubMed ID: 27423381
[TBL] [Abstract][Full Text] [Related]
7. Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.
Fang H; Shuang D; Yi Z; Sheng H; Liu Y
Biomed Pharmacother; 2016 Oct; 83():64-69. PubMed ID: 27470551
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analyses of significant prognostic risk markers for thyroid papillary carcinoma.
Min XS; Huang P; Liu X; Dong C; Jiang XL; Yuan ZT; Mao LF; Chang S
Tumour Biol; 2015 Sep; 36(10):7457-63. PubMed ID: 25908172
[TBL] [Abstract][Full Text] [Related]
9. A systematic study on dysregulated microRNAs in cervical cancer development.
He Y; Lin J; Ding Y; Liu G; Luo Y; Huang M; Xu C; Kim TK; Etheridge A; Lin M; Kong D; Wang K
Int J Cancer; 2016 Mar; 138(6):1312-27. PubMed ID: 26032913
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression profiling and Notch1 and Notch2 expression in minimal deviation adenocarcinoma of uterine cervix.
Lee H; Kim KR; Cho NH; Hong SR; Jeong H; Kwon SY; Park KH; An HJ; Kim TH; Kim I; Yoon HK; Suh KS; Min KO; Choi HJ; Park JY; Yoo CW; Lee YS; Lee HJ; Lee WS; Park CS; Lee Y;
World J Surg Oncol; 2014 Nov; 12():334. PubMed ID: 25381598
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the microRNA profile in early-stage cervical squamous cell carcinoma by next-generation sequencing.
Lin W; Feng M; Chen G; Zhou Z; Li J; Ye Y
Oncol Rep; 2017 Mar; 37(3):1477-1486. PubMed ID: 28098890
[TBL] [Abstract][Full Text] [Related]
12. Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
Qi Y; Lai YL; Shen PC; Chen FH; Lin LJ; Wu HH; Peng PH; Hsu KW; Cheng WC
Sci Rep; 2020 Dec; 10(1):22270. PubMed ID: 33335254
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of miRNA-21 and their potential as biomarkers for the diagnosis of cervical cancer.
Han Y; Xu GX; Lu H; Yu DH; Ren Y; Wang L; Huang XH; Hou WJ; Wei ZH; Chen YP; Cao YG; Zhang R
Int J Clin Exp Pathol; 2015; 8(6):7131-9. PubMed ID: 26261606
[TBL] [Abstract][Full Text] [Related]
15. Patterns of known and novel small RNAs in human cervical cancer.
Lui WO; Pourmand N; Patterson BK; Fire A
Cancer Res; 2007 Jul; 67(13):6031-43. PubMed ID: 17616659
[TBL] [Abstract][Full Text] [Related]
16. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients.
Li X; Tian R; Gao H; Yang Y; Williams BRG; Gantier MP; McMillan NAJ; Xu D; Hu Y; Gao Y
Sci Rep; 2017 Nov; 7(1):16495. PubMed ID: 29184082
[TBL] [Abstract][Full Text] [Related]
17. A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma.
Zhang J; Chong CC; Chen GG; Lai PB
PLoS One; 2015; 10(6):e0128628. PubMed ID: 26046780
[TBL] [Abstract][Full Text] [Related]
18. Identification of a seven-miRNA signature as prognostic biomarker for lung squamous cell carcinoma.
Gao X; Wu Y; Yu W; Li H
Oncotarget; 2016 Dec; 7(49):81670-81679. PubMed ID: 27835574
[TBL] [Abstract][Full Text] [Related]
19. Developing a prognostic micro-RNA signature for human cervical carcinoma.
How C; Pintilie M; Bruce JP; Hui AB; Clarke BA; Wong P; Yin S; Yan R; Waggott D; Boutros PC; Fyles A; Hedley DW; Hill RP; Milosevic M; Liu FF
PLoS One; 2015; 10(4):e0123946. PubMed ID: 25880806
[TBL] [Abstract][Full Text] [Related]
20. Use of Mature miRNA Strand Selection in miRNAs Families in Cervical Cancer Development.
Granados-López AJ; Ruiz-Carrillo JL; Servín-González LS; Martínez-Rodríguez JL; Reyes-Estrada CA; Gutiérrez-Hernández R; López JA
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
